Didn't find what you were looking for?

Feel free to reach out to us.

+91
Or reach us directly
Chat With Us
×

Dr. Abha Kumari

Home> Our Doctors Dr. Abha Kumari
Dr. Abha Kumari

Dr. Abha Kumari

QualificationMBBS , DNB Radiotherapy

SpecialitiesRadiation Oncology

Experience9 years
Book an Appointment

Area of Expertise

  • Experienced in administering high end radiotherapy techniques like 3DCRT, IMRT, VMAT, respiratory gating therapy, IGRT, SRS, SRT, brachytherapy etc    
  •  Extensive experience in research in the field of head and neck cancer and breast cancer    
  • Worked with renowned healthcare institutions like Amrita Institute Medical Science, Kerala, Tata Medical Centre, Kolkata, International Oncology Group, Fortis, Noida and Mahavir Cancer Sansthan, Patna. 

Research & Publications

  •   Rita R, Singh U, Trivedi V, Chauhan R, Kumari A (2017) Determinants of Survival of Cervical Cancer: A Hospital Based Study. Gynecol Obstet 7: 437. doi:10.4172/2161-0932.1000437.    
  • Chatterjee S, Chakraborty S; HYPORT Adjuvant Author Group.
  • Hypofractionated radiation therapy comparing a standard radiotherapy schedule (over 3 weeks) with a novel 1-week schedule in adjuvant breast cancer: an open-label randomized controlled study (HYPORT-Adjuvant)-study protocol for a multicentre, randomized phase III trial. Trials. 2020;21(1):819. Published 2020 Sep 30. doi:10.1186/s13063-020-04751-y    
  • S. Bhusal, S. Chatterjee, S. Chakraborty, A. Kumari, S. Bachianathan, A. Mahato, P. Lal, S. Gupta, P. Solomon, K.M. Das, S. Mandal. PO-1797: Dosimetric analysis of simultaneous integrated boost in the HYPORT Adjuvant Trial (NCT03788213). DOI:10.1016/S0167-8140(21)01815-6. ESTRO 2020 abstract    
  •  Ritesh santosham, Sanjoy Chatterjee, Santam Chakraborty, Avipsa Das, Abha Kumari Hypofractionated Radiotherapy with SIB in Advanced Incurable Breast Cancer -HYPORT B study (NCT03669497). DOI:10.13140/RG.2.2.36479.64160, ESTRO 2020 abstract                              

Medical Breakthrough

  • Clinical Research      Co-investigator in National cancer registry program (NCRP) in Mahavir Cancer Sansthan, Patna    
  • Principal investigator in Quality of life and employment status in head and neck cancer patients from rural area, treated at a tertiary cancer center in tier II city of India: A Prospective cross-sectional study    
  • Co-investigator in a Intensifying radiation treatment in advanced/ poor prognosis laryngeal, hypopharyngeal (LH) and oropharyngeal cancers (OPC) using PET –CT based dose escalation strategies. (INTELHOPE)    
  • Co-investigator in HYPOfractionated Radiation Therapy comparing a standard radiotherapy schedule (over three weeks) with a novel one-week schedule in Adjuvant breast cancer: An open label randomized controlled study (HYPORT- Adjuvant)    
  •  Co-Investigator in Hypofractionated Radiotherapy schedule of 26 Gy in 5 fractions with simultaneous integrated boost (6 Gy) in advanced incurable breast cancer: A prospective Phase I/II study.     Co-Investigator in a prospective, multicenter, randomized, double blind, parallel group study to compare the efficacy and safety of biosimilar cetuximab versus innovator cetuximab in combination with platinum-based chemotherapy in patients with recurrent locoregional or metastatic squamous cell carcinoma of the head and neck (ALK18/ENZ124-CET1)    
  • Co-investigator in a phase III, double-blind, placebo-controlled, randomized trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumors (ADD-Aspirin, breast cancer cohort)    
  • Co-investigator in a Phase III, Multicenter, Randomised, Double-Blind, Placebo-Controlled Study of Atezolizumab (Anti−PD-L1 Antibody) in Combination with Paclitaxel Compared with Placebo with Paclitaxel for Patients with Previously Untreated Inoperable Locally Advanced or Metastatic Triple Negative Breast Cancer (MO39196)      
  • Co-investigator in a Phase II, multicenter, open-label, two-cohort, non-comparative study to assess the efficacy and safety

Other Doctors

Dr. Saket Sathe
Dr. Saket Sathe

MBBS, DNB (General Surgery), DNB (Genitourinary Surgery)

HCG Cancer Hospital, Borivali

View Profile Book an Appointment
Dr. Varun M
Dr. Varun M

HCG Cancer Hospital, Double Road,HCG Cancer Hospital, K. R. Road

View Profile Book an Appointment
Dr. Meetu Jain
Dr. Meetu Jain

MBBS, MD

HCG Cancer Hospital, Jaipur

View Profile Book an Appointment
Dr. LaguduPerraju Bhaskar Bhuvan
Dr. LaguduPerraju Bhaskar Bhuvan

MBBS, MD (Internal Medicine), DM (Medical Oncology), ECMO, MRCP UK (Medical Oncology), PDCR

HCG Cancer Hospital, Visakhapatnam

View Profile Book an Appointment
Dr. Prashant Puranik
Dr. Prashant Puranik

MBBS, MS (General Surgery), MCh (Plastic Surgery)

HCG Cancer Hospital, Double Road,HCG Cancer Hospital, K. R. Road

View Profile Book an Appointment
Dr. Arijit Bishnu
Dr. Arijit Bishnu

MBBS, MD (Pathology), DM (Clinical Hematology)

HCG Cancer Center - Ranchi,HCG Cancer Hospital, Kolkata

View Profile Book an Appointment
WhatsApp Icon
Doctor Find a Doctor Book Book an Appointment